Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Coronavirus vaccination |
Direct substance |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Travel vaccination given |
Direct substance |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Autogenous immunization |
Direct substance |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Autogenous vaccination |
Direct substance |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Single vaccination NOS |
Direct substance |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Single vaccination NEC |
Direct substance |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Other single vaccinations |
Direct substance |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Porphyromonas denticanis - gulae - salivosa bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
|
Vaccines allergy |
Causative agent (attribute) |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Adverse reaction caused by vaccine properly administered |
Causative agent (attribute) |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Cat allergy maintenance kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
Dog allergy initial kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
Horse allergy maintenance kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
Horse allergy initial kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
Dog allergy maintenance kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
House mite allergy vaccine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
Horse allergy vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
House mite allergy maintenance kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
House mite allergy initial kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
Cat allergy initial kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
Cat allergy vaccine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
Dog allergy vaccine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
House dust allergy vaccine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Administration of subcutaneous zoster virus live vaccine |
Direct substance |
False |
Vaccine |
Inferred relationship |
Some |
2 |
Allergic reaction caused by vaccine product (disorder) |
Causative agent (attribute) |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Rabies immune globulin 150u injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Hepatitis b immune globulin 217u injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Tetanus immunoglobulin 250iu injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Tetanus immunoglobulin 2500iu infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Hepatitis B immunoglobulin 1000iu powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Hepatitis B immunoglobulin 200iu powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Hepatitis B immunoglobulin 500iu powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Tetanus immunoglobulin 250iu injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
1 |
Rubella immunoglobulin 25,000iu powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vaccine |
Inferred relationship |
Some |
2 |
Administration of measles and rubella vaccine |
Direct substance |
False |
Vaccine |
Inferred relationship |
Some |
3 |
Administration of SARS-CoV-2 antigen vaccine |
Direct substance |
False |
Vaccine |
Inferred relationship |
Some |
1 |